21/01/2026 21:09
EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG and Allfunds Group plc reached an agreement on recommended acquisition by Deutsche Börse AG of Allfunds Group plc
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Deutsche Börse AG / Key words: Mergers & Acquisitionsbr/ Deutsche Börse AG: Deutsche Börse AG and Allfunds Group plc reached an agreement on recommended acquisition by... Lire...
21/01/2026 19:35
ACCESS Newswire Inc. : ACCESS Newswire to Present at the Dealflow Discovery Conference in Atlantic City, New Jersey
pistrongPresentation time: Wednesday, Jan 28 at 2:30pm ET/strong/i/ppistrongACCESS Newswire also is proud to sponsor the event as a Media Partner./strong/i/p pstrong id=datelineRALEIGH, NORTH CAROLINA / a href=https://www.accessnewswire.com/ACCESS Newswire/a / January 21, 2026 / /strongstrongACCESS... Lire...
21/01/2026 18:25
FRANCAISE ENERGIE : H1 2026 revenues up 15.4% compared to H1 2025 Four additional power generation units in Hauts-de-France to start up shortly, following the signing of the Gaz de Mines agreement Investment program in Norway continues
p align=centerstrongH1 2026 revenues up 15.4% compared to H1 2025/strong/p p align=centerstrongemFour additional power generation units in HautsdeFrance to start up shortly, following the signing of the Gaz de Mines agreement/em/strong/p p align=centerstrongemInvestment program in Norway... Lire...
21/01/2026 18:02
ABSCIENCES : AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
PRESS RELEASE AB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS MS UNTIL 2041 THIS IS THE FIRST COUNTRY DELIVERING THE MS PATENT MASITINIB HAS UNIQUE AND COMPETITIVE POSITIONING IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS DUE TO... Lire...
21/01/2026 18:00
ORPHAN SYNERGY EUROPE-PHARMA : OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument VEL101 Nantes, France, January 21, 2026 – 6pm CET OSE Immunotherapeutics SA ISIN: FR0012127173; Mnemo: OSE, today acknowledges the announcement by its partner Veloxis Pharmaceuticals,... Lire...
21/01/2026 17:47
EQS-News: CPI PROPERTY GROUP – Sustainable Finance Update
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: CPI PROPERTY GROUP / Key words: Financing/ESG br/ CPI PROPERTY GROUP – Sustainable Finance Update br/br/ 21.01.2026 / 17:47 CET/CESTbr/ The issuer is solely... Lire...
21/01/2026 17:45
COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN : Michelin Free Cash Flow exceeds forecast in 2025
Group ClermontFerrand, January 21st, 2026 – 05:45pm COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin Free Cash Flow exceeds forecast in 2025 Michelin Group records in its... Lire...
21/01/2026 17:45
IPSEN : Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Press Release Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma PARIS, FRANCE, 21 January 2026 – Ipsen Euronext: IPN; ADR: IPSEY announced that the Arbitral Tribunal of the International Chamber of Commerce ICC has issued a final decision in favor of... Lire...